Latest Technetium-99m Stories
SNM survey of nuclear pharmacies finds patient rescheduling, delayed tests.
MAPLE Reactors Could Solve the Isotope Crisis within 24 months OTTAWA, July 30 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has submitted a Proposal to the Government of Canada's Expert Review Panel on Medical Isotope and Technetium-99m (Tc-99m) Generator Production.
SNM and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of Molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.
A world-wide shortage of a crucial radioisotope threatens to set back the quality of medical care several decades, U.S. doctors said. Technetium-99m is used in more than 40,000 medical procedures in the United States each day.
New Partnership Seeks to Strengthen Fragile Medical Isotope Supply Chain OTTAWA, June 15 /PRNewswire-FirstCall/ - MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, today announced that the Company and the Karpov Institute of Physical Chemistry in Moscow, Russia, have agreed to study the feasibility of the Karpov Institute providing the Company with a viable and reliable supply of Molybdenum-99 (Mo-99) for the global nuclear...
OTTAWA, May 19 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, has received information from its primary supplier, Atomic Energy of Canada Limited (AECL), regarding an interruption in the supply of medical isotopes, primarily molybdenum-99 (Mo-99) used in the manufacturing of technetium-99m generators. AECL has advised MDS Nordion that they anticipate the National Research Universal reactor (NRU) will remain out of service for more than...
Exclusive distribution agreement in place with GE Healthcare NOIDA, India, May 4 /PRNewswire/ - Jubilant Organosys Ltd, headquartered in India, announced today that its subsidiary in the United States, DRAXIMAGE LLC has received US Food and Drug Administration (FDA) approval for the Company's Abbreviated New Drug Application (ANDA) for DRAXIMAGE(R)'s generic Sestamibi.
By Strauss, H William; Miller, D Douglas; Wittry, Mark D; Cerqueira, Manuel D; Garcia, Ernest V; Iskandrian, Abdulmassi S; Schelbert, Heinrich R; Wackers, Frans J; Balon, Helena R; Lang, Otto; Machac, Josef I.
By MacDonald, Anita Burrell, Steven Nuclear medicine is a diverse field with a large number of different studies spanning virtually all organ systems and medical specialties.
By Liz Szabo Thousands of patients in the USA may face delays in getting key medical tests because of a global shortage of radioactive tracers, which are used to perform bone scans and to assess blood flow to the heart, experts say.